Overall, our study is the first attempts to evaluate the potential of combining imaging differences between SM and MM breast patient subgroups and YY1 gene expression, for a better diagnostic analysis of tumor metastasis (see Discussion). This evidence concerns the gene YY1 and Miyoshi myopathy.